A protocol for developing a clinical practice guideline for therapeutic drug monitoring of vancomycin

Abstract

This study aimed to develop a guideline for therapeutic drug monitoring (TDM) of vancomycin. We adopted the new guideline definition from the Institute of Medicine (IOM), adhered closely to the six domains of the Appraisal of Guidelines for Research & Evaluation II (AGREE II), and made recommendations based on systematic reviews. We established a Guideline Steering Group and a Guideline Development Group, formulated 12 questions in the form of Population, Intervention, Comparison, Outcome (PICO) and completed a literature search. As far as we know, we will develop the first evidenced-based guideline for vancomycin TDM under the framework of the Grade of Recommendations Assessment, Development and Evaluation (GRADE).

Keywords

vancomycin / therapeutic drug monitoring / guideline / Grade of Recommendations Assessment / Development and Evaluation

References

[1] CataldoMA, TacconelliE, GrilliE, et al. . Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis. J Antimicrob Chemother, 2012, 67(1): 17-24 PMID: 22028203

[2] YeZK, TangHL, ZhaiSD. Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis. PloS one, 2013, 8(10): e77169 PMID: 24204764 PMCID: 3799644

[3] RybakM, LomaestroB, RotschaferJC, et al. . Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm, 2009, 66(1): 82-98 PMID: 19106348

[4] MatsumotoK, TakesueY, OhmagariN, et al. . Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. J Infect Chemother, 2013, 19(3): 365-380 PMID: 23673472

[5] YeZK, LiC, ZhaiSD. Guidelines for therapeutic drug monitoring of vancomycin: a systematic review. PloS One, 2014, 9(6): e99044 PMID: 24932495 PMCID: 4059638

[6] Institute of Medicine: Clinical Practice Guidelines We Can Trust. Washington, DC: The National Academies Press, 2011

[7] GuyattGH, OxmanAD, VistGE, et al. . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 2008, 336(7650): 924-926 PMID: 18436948 PMCID: 2335261

[8] The AGREE Next Steps Consortium. Appraisal of Guidelines for Research and Evaluation, 2009. Available: http://www.agreetrust.org/ (accessed 2 June 2013)

[9] World Health Organization: WHO Handbook for Guideline Development, 2012. Available: http://apps.who.int/iris/bitstream/10665/75146/1/9789241548441_eng.pdf (accessed 2 Nov 2013)

[10] ChenYL, NorrisS, ChenH, et al. . The development of a global practie guidelines registry platform, 20143

[11] http://www.guidelines-registry.org/

[12] JaeschkeR, GuyattGH, DellingerP, et al. . Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ, 2008, 337: a744 PMID: 18669566

[13] The RIGHT Group: Essential Reporting Items for Practice Guidelines in Healthcare (RIGHT). 2014. cited 2014 http://www.right-statement.org/ (accessed 5 May 2014)